European Atherosclerosis Society/LinkedIn
Oct 6, 2026, 09:20
EAS Rare Lipid Disorder Course – Advancing Lipid Disorder Education – European Atherosclerosis Society
European Atherosclerosis Society shared a post on LinkedIn:
“Another wonderful confirmation of what EAS stands for!
The Rare Lipid Disorder Course in Buenos Aires, Argentina, was an incredible success.
Participants left the meeting room not only with new knowledge, but also inspired by the exchange of ideas, experiences, and perspectives.
A huge thank you to all the participants for making the course so engaging and, of course, to the organisers, Prof Pablo Corral and Laura Schreier, for making it happen! 👏
Would you like to be part of an educational activity like this in your country?
Take a look at our calendar and discover what’s coming up.
The next event is coming soon to Rome, Italy!”

Stay updates with Hemostasis Today.
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series
-
Nov 20, 2026, 17:16Raising Awareness of Bleeding Disorders in Women Through the Red Flag Campaign – Perth Blood Institute
-
Nov 20, 2026, 15:11Muhammet Ă–zbilen: Rivaroxaban vs Apixaban – The Menstrual Bleeding Difference
-
Nov 20, 2026, 14:54Fostamatinib in Immune Thrombocytopenia: Targeting Spleen Tyrosine Kinase to Reduce Platelet Destruction
-
Nov 20, 2026, 14:37Giuseppe Leone: The Evolving Treatment Landscape of Adult ITP